Hospitalizations in patients with idiopathic pulmonary fibrosis

Please find below a podcast of Dr Hyun Kim and Dr Joao de Andrade discussing data from the IPF-PRO Registry on the impact of hospitalizations in patients with IPF.

Blue Mic
Header - Navigation Icon

The IPF-PRO™ Registry is funded by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and co-ordinated by the Duke Clinical Research Institute (DCRI). The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors did not receive payment for the development of this podcast or the article on which it was based. Writing support was provided by Julie Fleming and Wendy Morris of Fleishman-Hillard, London, UK, which was contracted and funded by Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim was given the opportunity to review the article and podcast for medical and scientific accuracy as well as intellectual property considerations.